r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

TI

Tiffany Eul Davis Inglis

Insider · Chief Medical Officer · SERA

Tiffany Eul Davis Inglis files insider transactions with the SEC as a chief medical officer of Sera Prognostics. We hold 2 disclosed purchases and sales filed since 15 October 2025, 2 of them in the last 90 days.

  • Files forSERA
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure11 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 October 2025 — 10 September 2026Chief Medical Officer · Sera Prognostics 8 Form 4 lines · source: SEC Form 4

Every transaction

8 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
8 of 8 shown
10 Sep 202611 Sep 2026SEC Form 41 dsold on the open marketSera Prognostics486 sharesdown −1.0%up +0.0%
11 Jun 202615 Jun 2026SEC Form 44 dsold on the open marketSera Prognostics362 sharesup +5.2%up +10.3%
12 Mar 202613 Mar 2026SEC Form 41 dwas grantednot a tradeSera Prognostics17,437 sharesup +2.0%down −4.7%
12 Mar 202613 Mar 2026SEC Form 41 dwas grantednot a tradeSera Prognosticsderivative27,034 sharesup +2.0%down −4.7%
12 Mar 202613 Mar 2026SEC Form 41 dwas grantednot a tradeSera Prognosticsderivative27,034 sharesup +2.0%down −4.7%
12 Mar 202613 Mar 2026SEC Form 41 dwas grantednot a tradeSera Prognostics17,437 sharesup +2.0%down −4.7%
15 Oct 202515 Oct 2025SEC Form 40 dwas grantednot a tradeSera Prognosticsderivative107,000 sharesdown −35.1%down −35.1%
15 Oct 202515 Oct 2025SEC Form 40 dwas grantednot a tradeSera Prognostics75,000 sharesdown −35.1%down −35.1%

Both percentages are the stock’s move, not Tiffany Eul Davis Inglis’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 8 of the 8 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.